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Introduction 
An understanding of evidence-based medicine and how to implement it into practice 
has become an essential requirement for all healthcare professionals but keeping 
current with an ever growing body of new evidence is a challenge (1). As clinical 
practice becomes busier, time for reading and reflecting on the medical literature 
becomes ever more precious and difficult to protect.  This is particularly the case for 
‘generalist’ staff or those on-call and working outside their area of expertise. 
 
At the same time, developments in the health sector, in information systems and in 
health data networks have led to a vast array of information available to clinicians. 
There are over 20 million medical articles available today with thousands of medical 
journals being published worldwide every month (1). Clinicians are estimated to need 
to read 17 articles per day, every day of the year in order to stay abreast of relevant 
developments and inform their practice  with current research evidence, an 
impossible task for even the most dedicated and tireless clinician (2). Alongside 
primary information sources there are also a vast range of secondary 
resources such as databases and tertiary resources such as knowledge 
resources. Knowledge resources synthesize information gained from primary 
sources and are designed to be more convenient and quicker and easier to 
use (3). 
 
Map of Medicine is an evidence-based online clinical knowledge resource that is 
regularly updated. Using a pathway approach (fig 1) it provides a visual 
representation of evidence-based practise-informed care journeys covering 390 
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pathways in 28 medical specialities. The concept of the Map of Medicine was first 
devised in 2001 by medical entrepreneur Dr Mike Stein and Prof. Owen Epstein, who 
were part of a development team working to reduce clinic waiting times in the face of 
increasing referral numbers. The team found that the quality of referrals had a major 
impact on waiting times and that by making specialist knowledge available to 
community-based clinicians it improved referrals. Thus the Map of Medicine was 
born as a tool to make specialist knowledge available to clinicians and improve 
dialogue between primary and secondary care. The resource was developed as a 
commercial venture with the financial support of University College London and the 
Royal Free Hampstead NHS Trust. As demand for the resource grew amongst 
healthcare communities in the UK, the business was acquired by international 
publishers Informa plc in June 2005 and then by the Hearst corporation in April 2008. 
 
NHS Connecting for Health a Directorate of the Department of Health created 
to bring in new systems and services, has purchased the licenses to Map of 
Medicine on behalf of Local Service Providers at significant cost1.  These 
licenses enable access to the Map of Medicine through a variety of portals, 
such as NHS Evidence for NHS staff, a part of National Institute for Health and 
Clinical Excellence (NICE), which is an electronic portal to high quality 
electronic clinical and non-clinical evidence and information about health and 
social care. As well through NHS Choices for patients and public information. 
It is deployed across the UK by the Strategic Health Authorities in England, 
                                               
1 NHS Connecting for Health was created in April 2009 and was a new directorate with the 
combined responsibility for the delivery of the National Programme for IT and the management 
of the IT-related functions of the NHS Information Authority (NHSIA) which closed.  
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and Informing Healthcare, the Welsh-Assembly-funded health IT programme in 
Wales, with help from Connecting for Health and the Map of Medicine Central 
Team who supported early adopter NHS organisations to develop specialist 
clinical pathways. The resource has also been purchased by the National 
Boards of Health in Sweden and Denmark (4, 5).  
 
Given the investment in the Map of Medicine by the Department of Health in the UK 
in the development, deployment, funding of the license, and in staff time as well as 
the investment by healthcare providers in Sweden and Denmark, it is important to 
establish the beneficial impact that investment has had on healthcare practice and, 
ultimately, on patient outcomes.  Thus, the aim of this study is to conduct a 
systematic review of the published literature on the Map of Medicine to determine the 
extent of the evidence for its impact on clinical practice at the current time. 
 
Methods 
In order to access the peer reviewed literature relating to Map of Medicine, all of the 
NHS  Evidence healthcare databases (including AMED, BNI, CINAHL, Embase,  
Health Business Elite, HMIC, MEDLINE, PsycINFO) were searched for articles 
containing the following search term (“map of medicine”) in the title and text. These 
databases signpost literature from international journals and across a broad range of 
healthcare disciplines. Google Scholar which is a more generic academic web 
search engine was also searched for the same search term anywhere in the article. 
The searches were restricted to papers written in the English language that had 
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been published since January 2001 when the Map of Medicine was first developed.  
The Map of Medicine company website was also searched for additional peer 
reviewed articles that were not identified through the formal search. 
The grey literature was explored by two different routes.  In order to assess the types 
of literature that were discussing the Map of Medicine, the same search term (“map 
of medicine”) was entered into Google, limiting the findings to between 2001 and the 
present day.  This retrieved 124,000 hits, of which the first 1000 were screened.  In 
addition, the Map of Medicine company website was searched for articles that 
presented data but had not been published in peer-reviewed journals. All of the 
searches were performed on the 23rd of February 2010.    
Duplicate articles were removed and the remaining articles were screened.  The 
inclusion criteria were that the articles had to be relevant to the research question: 
“What impact has the Map of Medicine had on clinical practice?” and must present 
empirical data on this topic. 
The final group of articles were read in full and independently by the three authors.  
Data were extracted separately by each author using a common framework for data 
extraction.  The authors then met to discuss the findings and identify key themes 
across the articles. The quality of peer-reviewed articles was assessed using the 
most appropriate tool given the content of the paper. 
Results 
Literature identified 
The literature search identified 133 articles, derived from the NHS Evidence 
databases (36), Google Scholar (75) and the Map of Medicine website (22). The 
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Google search yielded mainly documents and websites from Strategic Health 
Authorities and Healthcare Trusts referring to the Map of Medicine and offered no 
new leads.  
There were 16 duplicate items, 16 irrelevant articles and 66 were publications where 
the Map of Medicine was mentioned only briefly (fig 2). Of the remaining 35 items, 12 
of the papers were classified by the researchers as resource descriptions (6-17), which 
contained descriptive information about the Map of Medicine but no evidence of its 
impact on clinical practice and were thus excluded. Eight newsletters(18-25) and four 
case studies (26-29) were excluded for the same reason. 
The remaining 11 items, that were relevant to the research question and presented 
empirical data or statements about key findings, consisted of 1 peer-reviewed journal 
article presenting primary research (30), 8  case studies (31-38) and 2 newsletters 
containing articles which presented empirical data (39, 40).  
Quality assessment of selected  papers 
The quality of the one peer-reviewed paper was assessed using the Cochrane 
Effective Practice and Organisation of Care (EPOC)2 Group tool for evaluating 
interrupted time series designs (41). The assessment showed that the quality of 
the paper was sub-optimal, particularly within the analysis and reporting. The 
use of a time series analysis could have provided good evidence of a “fall in 
the total number of referrals” but, for this, Automated Regressive Integrated 
                                               
2 This group is a collaborative review group of the Cochrane Collaboration that aims to help people 
make well-informed decisions about health care by preparing, maintaining, and ensuring the 
accessibility of systematic reviews of the effects of health care interventions.  
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Moving Average (ARIMA) or time series regression modelling would have been 
required.  No rationale was provided for the number of data points collected 
and only two pre-intervention points were presented.  Closer inspection 
suggests the fall could have been part of an ongoing trend, but insufficient 
data are available to confirm or refute this.  
It was not possible to evaluate the quality of the research presented in the 
case studies or newsletter items due to the limited methodological detail 
provided. 
Evidence of impact 
i) Reduced referral to secondary care 
The one primary research study investigated the use of the Map of Medicine for 
assessing chronic kidney disease referrals in Gwent healthcare community in Wales 
(30).  The same findings were reported in less detail as a case study (31).  By 
analysing changes in the number of new referral letters received following the launch 
of the Map of Medicine-based chronic kidney disease patient referral pathway in 
November 2007, they found that there was an overall decrease in referrals from 
approximately 85% in September and October 2007 to approximately 60% between 
November 2007 and June 2008. By analysing patient referral letters in 6 consecutive 
months prior to and following the launch of the chronic kidney disease patient referral 
pathway, they also found that there was a decrease in referrals with inadequate 
information to secondary care from 23% to 14%. However there was a slight 
increase in inappropriate referrals from 13% to 16%. Furthermore they found that 
62% of all primary care practices in the Gwent healthcare community were 
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registered with the Map of Medicine after the intervention and that these practices 
sent a higher proportion of appropriate referrals and were less likely to generate 
referrals with inadequate information. 
Five of the 8 case studies also suggest that the Map of Medicine can lead to a 
decrease in inappropriate referrals. Newham Local Healthcare Community (LHC) 
used the Map of Medicine to communicate a new Anticoagulation pathway which 
resulted in 33% of stable patients being managed in primary care (33). The number of 
referrals from primary to secondary care for monitoring almost halved in the months 
after the pathway was implemented. Similarly, the introduction of  a diabetes 
pathway resulted in a reduction of 14% in the first to follow up3 ratios for Newham 
University Hospitals Trust, despite an increase in the number of outpatient 
attendance to secondary care (37). The introduction of a Knee Pain pathway in South 
Devon resulted in a 70% decrease in referral to secondary care and an increase in 
appropriate referrals (35). In Western Cheshire LHC the introduction of the Cellulitis 
pathway reduced hospital admissions by almost half (36). Finally, Wirral Primary Care 
Trust reported reduced referrals after the introduction of an incontinence and Age-
related Macular Degeneration (AMD) pathway (although exact figures were not 
reported in the case study) (32). 
 ii) Cost savings 
                                               
3 First to follow-up ratios are a type of performance measure usually calculated on a 
consultant basis to determine the numbers of follow up patients seen in comparison to new 
patients. As a rule of thumb, the higher the new to follow-up ratio, the more likely a significant 
proportion of a clinician’s time is being taken to for follow-up appointments at the expense of 
seeing new patients. 
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Some considerable cost savings were presented in the articles reviewed. For 
example, introducing the Newham Anticoagulation pathway produced estimated 
savings of £300,000 for 2009/2010 and up to £500,000 in 2010/2011 (33); and the 
Western Cheshire Cellulitis pathway was thought to save at least £2000 per patient 
(36). South Devon knee pain pathway projects a reduction of in excess of 400 
consultant appointments with a saving of at least £60,000 (35). Wirral AMD service 
reports that it is now delivered at a significantly lower cost than alternative providers 
with the cost reduction at approximately 20%. Overall savings from the new service 
at Wirral are reportedly in the order of £200,000 per year with costs reduced in both 
initial assessment and treatment tariffs (34). 
iii) Reduced patient waiting times. 
The introduction of the AMD pathway in Wirral led to an improvement in patient 
waiting times from 10 weeks to 10 days (32, 34). The adoption of the knee pain 
pathway in South Devon also resulted in reduced patient waiting times (although 
exact figures were not reported in the case study) (35).  
iv) Use as a training tool 
One of the newsletter articles interviewed 100 senior hospital doctors in England and 
Wales to find out which one of four key benefits they would find most useful about 
the Map of Medicine (39). The results indicated that the Map was rated most highly as 
a knowledge resource for training teams. Similarly a study of the viability of the 
mobile Map of Medicine found that it showed potential for formal clinical training (40). 
A quote from a GP in one of the case studies also stated that it was a good teaching 
resource for medical students (37).  
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v) Other benefits 
Other benefits may include reduced wastage from unnecessary pathology testing, 
greater confidence in dealing with matters outside their own expertise, support for 
teams seeking alternative diagnoses, better communication between care providers, 
or a more unified approach to evidence-based care (38). 
Discussion 
This study presents a systematic review of the literature on the Map of Medicine to 
determine the extent of the evidence for its impact on clinical practice at the current 
time.  The findings will help individuals and organisations to decide whether to invest 
in the Map of Medicine, and where and how it can be utilised to make the biggest 
impact for patients.  It will also help policy makers and researchers to set a research 
agenda that can generate evidence of impact for new initiatives on a timescale that 
can support policy decisions.  
The most important finding of the study is the paucity of evidence available on the 
impact of the Map of Medicine and the variable quality of that which does exist.  
There is only one article published in a peer-reviewed journal that presents empirical 
data relating to its impact. This seems astonishing, given the high level of financial 
investment by the Map of Medicine company and healthcare providers in the UK, 
Sweden and Denmark and highlights a need for more and better research in this 
area. The paucity of peer-reviewed literature may reflect the time involved in 
designing and performing rigorous research and this being written up, peer reviewed 
and published.  The Map of Medicine was first developed in 2001 but it has only 
been available in Trusts across England and Wales since 2006 and in Sweden and 
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Denmark even more recently. If this is the case, we hope that there will be an 
abundance of literature emerging in the coming months and years.  
Many of the studies had multiple aims and presented limited methodological detail.  
The multiple aims may be expected with interventions that are part of a service 
redesign project but made it difficult to establish the specific impact of an 
intervention.  The limited detail also made it difficult to establish the specific impact 
and proved a barrier to using inventories that could measure the quality of the 
research studies as we had intended (42). Furthermore, there appeared to be some 
flawed conclusions within the studies.  For example, in two of the case studies, the 
results showed a shorter patient journey but the conclusions reported a better patient 
experience (32, 35). We would argue that, although a shorter patient journey may result 
in a better patient experience, this is not necessarily the case. 
The potential for bias in the literature was high. The case studies were numerically 
the largest source of evidence for impact but because they were not peer reviewed 
and were published largely as promotional material on the Map of Medicine website, 
there is considerable potential for bias or selective publication. In addition, the case 
studies were written by healthcare communities that participated in the Map of 
Medicine Early Adopter programme (41). Early Adopters received free consulting 
resources and training support and, in return, were required to write a number of 
case studies.  Importantly, there are certain pre-requisite criteria to becoming an 
Early Adopter (e.g. specific business challenge, specific and measurable outcomes) 
and this may mean that only those likely to be successful participated.  
It is important to be clear that the dearth of quality literature at the current time 
indicates that we have insufficient evidence about the impact of the Map of Medicine 
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on clinical practice, rather than that the evidence suggests that there is no impact.  
Indeed there are some encouraging early indications, particularly for the Map of 
Medicine as a tool within service redesign, where it seems to be leading to an 
increase in appropriate referrals, decreased patient waiting times and considerable 
cost savings. However, these improvements may have occurred through 
service redesign intervention that did not involve the Map of Medicine and 
different study designs are required to attribute any improvement to a specific 
cause. The Map of Medicine is also perceived by clinicians as a valuable training 
tool and, again, evidence of its education impact will be difficult to prove. 
One interesting theme emerging from our review was around the changing role for 
the Map of Medicine within healthcare.  The Map of Medicine was initially designed 
as a knowledge resource to make specialist knowledge available to community-
based clinicians and improve dialogue between primary and secondary care.  More 
recently, however, it seems to have found a niche as a service redesign tool.  
Possible future applications seem to be a role in clinician training.  It is interesting to 
speculate on the reasons for these changes.  One case study suggests that anxiety 
around the Map of Medicine’s potential to reduce the need for clinical judgement has 
formed a barrier to its uptake and usage (27). It could be that the resource has 
specific uses for different people in different healthcare roles. GPs may find the 
primary care part of the Map and the crossover to secondary care most beneficial. 
Healthcare students and educators may find the whole Map useful in providing a 
visual framework of a complete patient journey. Healthcare managers may find the 
overview useful to aid service re-design and quality improvement.  
 
13 
 
Strength and limitations of the study 
It is important to consider both the strengths and limitations of our study. The topic is 
important and the study is timely, given the financial climate in which decisions are 
having to be made. This systematic review involved a wide ranging literature search. 
Three different authors read each of the papers in full which ensured rigour in the 
review and resulted in different perspectives on the literature found. Whilst this paper 
focuses on the Map of Medicine, it may raise a similar lack of evidence for the impact 
of other healthcare interventions, particularly e-resources. 
A limitation of the study is that despite the wide ranging literature searched, as with 
all systematic reviews, there may have been some literature missed, including 
literature published in languages other than English, particularly Danish and 
Swedish. Furthermore, the search terms used would not have found studies on 
similar resources with different names, which could have contributed to a full picture. 
Another possible limitation relates to the potential bias of the authors, who were two 
academic staff members at a medical school (initials and initials) and an NHS 
employee in the Strategic Health Authority (initials).  We sought to ensure a 
balanced appraisal of the literature through our structured review process and by 
ongoing reflection on the process and our own potential bias, and this was a regular 
agenda item for the research team meetings.  
Conclusions 
The absence of quality evidence on the impact of the Map of Medicine will 
make decisions about whether to invest in the Map of Medicine, and where and 
how it can be utilised to make the biggest impact for patients, more difficult.  
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Research is urgently needed to answer these important questions and support 
decision-making.   
 
Further research with rigorous study designs performed by professional 
researchers are needed.  Randomised controlled study designs are unlikely to 
be possible but well-designed quasi-experimental and qualitative studies will 
help.  We would encourage LHC’s to design their evaluations with the rigour 
required for research publication and incentivise their staff to make them 
available to a wider audience via the academic literature. This may require 
partnerships between clinical and academic communities, in line with recent 
UK healthcare initiatives (e.g. CLAHRCs4, HIECs5).  
 
Finally, large funded projects need to earmark sufficient resources to enable 
rigorous evaluation of the impact of the developments to take place and these 
evaluations need to be planned at the outset, rather than done retrospectively. 
 
Key Messages 
Implications for Practice 
1. The Map of Medicine has many potential applications in healthcare.  
                                               
4 http://www.nihr.ac.uk/infrastructure/Pages/infrastructure_clahrcs.aspx 
 
5 http://www.nesc.nhs.uk/about_nesc/hiecs.aspx 
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2. The Map of Medicine is emerging as a key tool within service redesign, 
leading to an increase in appropriate referrals to secondary care, decreased 
patient waiting times and considerable cost savings.  
3. The Map of Medicine is perceived by clinicians as a valuable training tool. 
 
Implications for Policy 
1. There is a paucity of evidence available on the impact of the Map of Medicine 
on clinical practice. 
2. The evidence which does exist is of variable quality. 
3. Further research is needed to provide evidence of the impact of Map of 
Medicine on clinical practice in order to support policy decisions. 
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